Ceftriaxone Sodium 1000mg Injection
Formulation Overview: Flagship once-daily 1 g parenteral third-generation cephalosporin powder vial delivering high CNS, biliary, and pulmonary tissue concentrations across severe hospital bacterial infections. Formulated with Ceftriaxone Sodium USP / IP (eq. Ceftriaxone 1000 mg) (1000 mg (1 g)) in Sterile Dry Powder Injection Vial dosage form under Anti-Infectives & Antibiotics, manufactured to IP / BP / USP Compendial standards and supplied in 1g USP Type I Glass Vial + 10 ml Sterile WFI Ampoule in Tray with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
| Item Code (SKU) | AKP-044 |
| Therapeutic Sector | Anti-Infectives & Antibiotics |
| Dosage Form | Sterile Dry Powder Injection Vial |
| Active Ingredient | Ceftriaxone Sodium USP / IP (eq. Ceftriaxone 1000 mg) |
| Strength / Purity | 1000 mg (1 g) |
| Clinical Indication | Bacterial meningitis, enteric typhoid fever, community-acquired pneumonia, septicemia, and complicated UTI |
| Specification Standard | IP / BP / USP Compendial |
| Packaging Format | 1g USP Type I Glass Vial + 10 ml Sterile WFI Ampoule in Tray |
| Shelf Life | 24–36 Months |
| Storage Conditions | Store below 25°C; protect from light & moisture |
| Minimum Order Quantity | 1000 Packs |
| Regulatory / Analytical Docs | Full eCTD / ACTD Modules 1–5 + Zone IVb Stability Available |
| African & Global NRA Readiness | NAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA |
| Stock Availability | In Stock · Immediate Commercial Dispatch |
| Supply Status | Commercial Export Ready |